Viral Vectored Vaccines against InfluenzaVaccines are efficacious and cost-effective preventative healthcare measures and a global mainstay in protecting millions from infectious disease. Dr. Lambe’s research interest lies in the development of efficacious vaccines, principally toward influenza and emerging pathogens. Viral vectors have become a vaccine platform of choice for many pathogens that have evaded conventional vaccination approaches. Dr Lambe will discuss the broad applicability of viral vectors as a platform technology with a focus on their use for the prevention of influenza-mediated disease.
If you would like to attend this seminar, please contact us to arrange site access - email@example.com
|Starts||12:00 pm - 18/07/2018|
|Ends||01:00 pm - 18/07/2018|
|Location||The Cambridge Building - Kings Hedges Room|
|Speaker||Dr Teresa Lambe|
|Speaker Affiliation||The Jenner Institute, University of Oxford|
10 July, 2018